hologram on an euro bill

Your leading venture capital adviser with innovative Solutions

Venture capital transactions are a key strength of CMS Germany. Clients and the prestigious JUVE Handbook rank us among the top venture capital practices in Germany.

Tier 1 and 2 – JUVE Handbook, 2014/2015

By developing innovative solutions, we have become widely recognised as a pioneering player and standard setter. In addition to our focus on transactions, we have broad-based, in-depth expertise in all relevant legal areas.

Global markets in view

Our clients (investors and technology-oriented start-ups) benefit from our expertise in dynamic sectors such as biotech, cleantech, IT, medtech, pharmaceuticals, telecommunications, software and eCommerce.

As a member of the international CMS organisation, we provide you with direct access to resources that span more than 71 offices in over 40 countries. Strong partner involvement in the advisory teams guarantees efficient and high-quality advice – at both national and cross-border level.

Our service portfolio covers every Topic

We advise our clients throughout the acquisition and ownership phases – from the initial investment through further rounds of financing and restructuring of the venture capital-financed companies, right up to exit.

Investment

  • Transaction structuring
  • Cross-border "flips" or "re-flips" in preparation for investment
  • Drafting and negotiating letters of intent and/or term-sheets
  • Due diligence Preparing agreements and resolutions
  • Contract negotiations
  • Transaction management
  • Assistance with post-closing activity

Portfolio support

  • Advice on further rounds of financing
  • Non-dilutive financing (e.g. venture loans)
  • Providing assistance for shareholders' meetings
  • and general meetings Preparing shareholder resolutions
  • CEO and directors' service contracts
  • Employee stock option programmes
  • Support for operational activities
  • Preparing for restructuring and expansion

Exits

  • Trade sale
  • Secondary transactions
  • Merger, share exchange
  • IPO Agreements with M&A advisers

Sehr kommunikationsstark und gleichzeitig extrem gut darin, rechtliche Zusammenhänge einfach zu klären.

The Legal 500 Deutschland, 2020

Keine Verschwendung von Arbeitszeit für unnötigen Papierkram und keine Angst vor extrem knackigen Deadlines.

The Legal 500 Deutschland, 2020

They are very experienced, pragmatic, and have a specialist for every topic.

Chambers Europe, 2019

Eine häufig empfohlene Kanzlei für PE, und führend in VC, die alljährl. ihre enorme Bandbreite sowohl in der Mid-Cap-Arbeit als auch in VC unter Beweis stellt.

JUVE Handbuch 2014/2015

Eine führende Kanzlei für PE u. VC, deren Praxis als breiteste im Markt gilt – u. stetig weiterwächst.

Chambers Europe, 2013

Feed

20/06/2022
CMS ad­vises Treas­ury In­tel­li­gence Solu­tions on the ac­quis­i­tion of Cash­force
Mu­nich – Treas­ury In­tel­li­gence Solu­tions (TIS) ac­quires Cash­force, a Bel­gi­um-based FinTech start-up of­fer­ing AI-based cash man­age­ment and cash fore­cast­ing solu­tions. The ac­quis­i­tion of Cash­force is...
17/05/2022
CMS ad­vises Fuse Ven­ture Part­ners on in­vest­ment in di­git­al mar­ket­place...
Frank­furt/Main – Fuse Ven­ture Part­ners has par­ti­cip­ated in the EUR 9m Series A fund­ing of di­git­al mar­ket­place pro­vider Ma­ga­Loop. The fin­an­cing round was led by Mar­ket One Cap­it­al and At­lantic Food Labs...
03/05/2022
CMS ad­vises bi­o­tech­no­logy firm Tu­bulis on EUR 60 mil­lion Series B fin­an­cing...
Mu­nich – Bi­otech com­pany Tu­bulis has suc­cess­fully com­pleted a Series B round of fin­an­cing worth EUR 60 mil­lion. Three new in­vestors, An­dera Part­ners, Evotec SE and Fund+, joined the round. All the ex­ist­ing...
21/04/2022
CMS ad­vises founders and ma­jor­ity share­hold­ers of Sel­lics Mar­ket­place Ana­lyt­ics...
Ber­lin – Ber­lin-based soft­ware start-up Sel­lics Mar­ket­place Ana­lyt­ics GmbH has been fully ac­quired by As­cen­tial plc, a com­pany headquartered and lis­ted in Lon­don. Once the ac­quis­i­tion has been com­pleted...
27/01/2022
CMS ad­vises IN­ER­ATEC on Series A fin­an­cing round for pro­duc­tion of sus­tain­able...
Ber­lin – Karls­ruhe-based start-up IN­ER­ATEC has gained a num­ber of stra­tegic in­vestors to boost its pro­duc­tion ca­pa­city for syn­thet­ic fuels de­rived from CO2 and green hy­dro­gen. In­vestors in­clude en­ergy...
20/12/2021
CMS ad­vises real es­tate fintech start-up Urbyo on USD 5 mil­lion seed fin­an­cing...
Ber­lin – Real es­tate fintech Urbyo has raised more than USD 5 mil­lion in a seed round of fin­an­cing. The Ber­lin-based start-up op­er­ates an In­ter­net plat­form aimed at re­shap­ing the way prop­erty is bought...
06/12/2021
CMS ad­vises Ca­dence Growth Cap­it­al (CGC) on in­vest­ment in phone-as-a-ser­vice...
Stut­tgart – Phone-as-a-ser­vice pro­vider everphone has raised USD 200 mil­lion in growth cap­it­al. The round of fin­an­cing was led by Ca­dence Growth Cap­it­al (CGC), the fast­est grow­ing growth PE fund in...
03/11/2021
CMS ad­vises di­git­al start-up Qual­i­fyze on EUR 12 mil­lion Series A round...
Frank­furt/Main – Frank­furt-based di­git­al start-up Qual­i­fyze has re­ceived EUR 12 mil­lion of new cap­it­al in a Series A round of fin­an­cing to boost de­vel­op­ment of its cer­ti­fic­a­tion plat­form for the health­care...
20/09/2021
EGYM com­pletes suc­cess­ful USD 41 mil­lion round of fin­an­cing with CMS sup­port
Mu­nich – Mu­nich-based fit­ness tech start-up EGYM has raised USD 41 mil­lion in a Series E round of fin­an­cing. The round saw May­fair Equity Part­ners, a lead­ing growth in­vestor in the tech­no­logy and con­sumer...
15/09/2021
CMS ad­vises Siri­on Bi­otech share­hold­ers on ac­quis­i­tion by PerkinElmer
Mu­nich – Lis­ted US com­pany PerkinElmer, Inc. has ac­quired SIRI­ON BI­OTECH, a lead­ing glob­al pro­vider of vir­al vec­tor-based tech­no­lo­gies for cell and gene ther­apies. Siri­on has es­tab­lished a strong port­fo­lio...
25/08/2021
CMS ad­vises bi­otech com­pany Car­di­or Phar­ma­ceut­ic­als on EUR 64 mil­lion Series...
Mu­nich – Car­di­or Phar­ma­ceut­ic­als GmbH, a bi­otech firm headquartered in Han­over, has raised around EUR 64 mil­lion in a Series B round of fin­an­cing. Car­di­or de­vel­ops non-cod­ing RNA (ncRNA)-based thera­peut­ics...
07/07/2021
CMS ad­vises Frank­furt SaaS start-up ivi­cos on fin­an­cing round
Frank­furt/Main – Frank­furt-based SaaS start-up ivi­cos GmbH has se­cured fund­ing as part of a seed round of fin­an­cing. In­vestor is Ul­rich Dausi­en, the founder of Jack Wolf­skin. ivi­cos in­tends to use the...